Latest News for: h ii

Edit

HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025

Nasdaq Globe Newswire 20 Mar 2025
— SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a promising chemo-free oral treatment strategy to address ...
Edit

All In Capital launches Fund II with a target corpus of ₹200 crore

Business Line 20 Mar 2025
For Fund-II, the firm has already marked the first close at ₹100 crore, ...
Edit

HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer

Enid News & Eagle 20 Mar 2025
— SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO®in MET-high lung cancer, representing a promising chemo-free oral treatment strategy to address ...
Edit

Mark E. Sikora II

Williston Observer 20 Mar 2025
It is with great sadness that we announce the passing of Mark E. Sikora II March 8, 2025 ....
Edit

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common ...

Nasdaq Globe Newswire 20 Mar 2025
Multi-center clinical trial includes sites located in the US, UK and EU ... .
Edit

Division III hoops championship coming to Fort Wayne for final time; Division II set to ...

Fort Wayne Journal Gazette 20 Mar 2025
This week, Memorial Coliseum will play host to the Division III men’s basketball semifinals and championship game for the fifth and final time since 2019 ... .
Edit

Robert W. Jackson II

Calhoun Times 20 Mar 2025
April 2, 1947 - March 12, 2025 ....
Edit

All In Capital launches Fund II with Rs 200 Cr target corpus, makes first close ...

Your Story 20 Mar 2025
With its second fund, All In Capital plans to focus on consumer tech, deeptech, fintech, and consumer brands ....
Edit

Column: The importance of proofreading, Part II

Mount Pleasant Morning Sun 20 Mar 2025
Subscribe to continue reading this article ... Share this. ....
Edit

Pharming Group N.V., - Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation (Pharming Group NV)

Public Technologies 20 Mar 2025
Title Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation. Previous result.
Edit

Pedro Pascal at Worldwide Box Office: From Gladiator II to Wonder Woman 1984, ranking his last 5 films

Pinkvilla 20 Mar 2025
From Gladiator II to Wonder Woman 1984, here’s a look at his recent films and how they performed theatrically ... From Gladiator II to Wonder Woman 1984, ranking his last 5 films ... Gladiator II (2024) — USD 462.18 Million.
×